176 related articles for article (PubMed ID: 22778104)
21. Dose-dependant acute or subacute disease caused by Burkholderia pseudomallei strain NCTC 13392 in a BALB/c aerosol model of infection.
Funnell SGP; Tree JA; Hatch GJ; Bate SR; Hall G; Pearson G; Rayner EL; Roberts ADG; Vipond J
J Appl Microbiol; 2019 Oct; 127(4):1224-1235. PubMed ID: 31330088
[TBL] [Abstract][Full Text] [Related]
22. Role of Toll-Like Receptor 5 (TLR5) in Experimental Melioidosis.
Birnie E; Weehuizen TAF; Lankelma JM; de Jong HK; Koh GCKW; van Lieshout MHP; Roelofs JJTH; Budding AE; de Vos AF; van der Poll T; Wiersinga WJ
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109950
[TBL] [Abstract][Full Text] [Related]
23. Gene Expression Profile of Human Cytokines in Response to
Krishnananthasivam S; Sathkumara HD; Corea E; Natesan M; De Silva AD
mSphere; 2017; 2(2):. PubMed ID: 28435890
[TBL] [Abstract][Full Text] [Related]
24. BURKHOLDERIA PSEUDOMALLEI BIOFILM PLAYS A KEY ROLE IN CHRONIC INFLAMMATION IN C57BL/6 MICE.
Panomket P; Wongsana P; Wanram S; Wongratanacheewin S
Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):73-82. PubMed ID: 29644822
[TBL] [Abstract][Full Text] [Related]
25. Development of novel animal infection models for the study of acute and chronic Burkholderia pseudomallei pulmonary infections.
van Schaik E; Tom M; DeVinney R; Woods DE
Microbes Infect; 2008 Oct; 10(12-13):1291-9. PubMed ID: 18707015
[TBL] [Abstract][Full Text] [Related]
26. The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection.
Koo GC; Gan YH
BMC Immunol; 2006 Aug; 7():19. PubMed ID: 16919160
[TBL] [Abstract][Full Text] [Related]
27. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.
Jacquelin B; Mayau V; Targat B; Liovat AS; Kunkel D; Petitjean G; Dillies MA; Roques P; Butor C; Silvestri G; Giavedoni LD; Lebon P; Barré-Sinoussi F; Benecke A; Müller-Trutwin MC
J Clin Invest; 2009 Dec; 119(12):3544-55. PubMed ID: 19959873
[TBL] [Abstract][Full Text] [Related]
28. Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys.
Coleman C; Doyle-Meyers LA; Russell-Lodrigue KE; Golden N; Threeton B; Song K; Pierre G; Baribault C; Bohm RP; Maness NJ; Kolls JK; Rappaport J; Mudd JC
Front Immunol; 2021; 12():754642. PubMed ID: 34691074
[TBL] [Abstract][Full Text] [Related]
29. Heme Oxygenase-1 and Carbon Monoxide Promote Burkholderia pseudomallei Infection.
Stolt C; Schmidt IH; Sayfart Y; Steinmetz I; Bast A
J Immunol; 2016 Aug; 197(3):834-46. PubMed ID: 27316684
[TBL] [Abstract][Full Text] [Related]
30. Burkholderia pseudomallei triggers canonical inflammasome activation in a human primary macrophage-based infection model.
Lichtenegger S; Stiehler J; Saiger S; Zauner A; Kleinhappl B; Bernecker C; Schlenke P; Wagner GE; Krause K; Gastager M; Steinmetz I
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008840. PubMed ID: 33137811
[TBL] [Abstract][Full Text] [Related]
31. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
[TBL] [Abstract][Full Text] [Related]
32. Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates.
Cumont MC; Diop O; Vaslin B; Elbim C; Viollet L; Monceaux V; Lay S; Silvestri G; Le Grand R; Müller-Trutwin M; Hurtrel B; Estaquier J
J Virol; 2008 Feb; 82(3):1175-84. PubMed ID: 18032487
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice.
Amemiya K; Dankmeyer JL; Fetterer DP; Worsham PL; Welkos SL; Cote CK
Microb Pathog; 2015 Sep; 86():53-63. PubMed ID: 26162294
[TBL] [Abstract][Full Text] [Related]
34. Potential of repurposing chloroquine as an adjunct therapy for melioidosis based on a murine model of Burkholderia pseudomallei infection.
Ganesan N; Embi N; Hasidah MS
Trop Biomed; 2020 Jun; 37(2):303-317. PubMed ID: 33612800
[TBL] [Abstract][Full Text] [Related]
35. The lymphatic system as a potential mechanism of spread of melioidosis following ingestion of Burkholderia pseudomallei.
Nelson M; Nunez A; Ngugi SA; Atkins TP
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009016. PubMed ID: 33617546
[TBL] [Abstract][Full Text] [Related]
36. Caspase-1 mediates resistance in murine melioidosis.
Breitbach K; Sun GW; Köhler J; Eske K; Wongprompitak P; Tan G; Liu Y; Gan YH; Steinmetz I
Infect Immun; 2009 Apr; 77(4):1589-95. PubMed ID: 19179418
[TBL] [Abstract][Full Text] [Related]
37. Burkholderia pseudomallei Δ
Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
[No Abstract] [Full Text] [Related]
38. A Meta-Analysis of Rhesus Macaques (
Witt AN; Green RD; Winterborn AN
Comp Med; 2021 Oct; 71(5):433-441. PubMed ID: 34588096
[TBL] [Abstract][Full Text] [Related]
39. An objective approach for Burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing.
Van Zandt KE; Tuanyok A; Keim PS; Warren RL; Gelhaus HC
Front Cell Infect Microbiol; 2012; 2():120. PubMed ID: 23057010
[TBL] [Abstract][Full Text] [Related]
40. Release of pro-inflammatory cytokines TNF-α, IFN-γ and IL-6 by Burkholderia pseudomallei- stimulated peripheral blood mononucleocytes of acute myeloid leukemia patients.
Zulpa AK; Barathan M; Iyadorai T; Chandramathi S; Vellasamy KM; Vadivelu J; Gan GG; Anuar NA
Trop Biomed; 2021 Jun; 38(2):180-185. PubMed ID: 34172708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
